Keapstone Therapeutics launched in world-first partnership to develop new drugs for Parkinson’s
The University of Sheffield and Parkinson’s UK have launched a new £1million virtual biotech company in the next stage[1] of a pioneering...
Parkinson's UK & MedGenesis Therapeutix Inc. announce top-line results of Phase 2 GDNF safet
Parkinson's UK and MedGenesis Therapeutix Inc. announced today that the Phase 2 clinical trial evaluating the safety and efficacy of...